Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nps Pharmaceuticals Inc (NPSP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nps Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 890465.
Total stock buying since 2014: $0.
Total stock sales since 2014: $9,324,000.
Total stock option exercises since 2014: $2,800,431.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 39,333 | $1,805,084 | 176,109 | $1,621,677 |
| 2014 | 0 | $0 | 237,272 | $7,518,916 | 240,217 | $1,178,754 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-02 | 0 | $0 | 39,333 | $1,805,084 | 176,109 | $1,621,677 |
| 2014-12 | 0 | $0 | 95,590 | $3,332,619 | 93,090 | $516,921 |
| 2014-11 | 0 | $0 | 101,047 | $3,076,689 | 85,859 | $414,563 |
| 2014-10 | 0 | $0 | 40,635 | $1,109,608 | 0 | $0 |
| 2014-08 | 0 | $0 | 0 | $0 | 55,480 | $247,270 |
| 2014-06 | 0 | $0 | 0 | $0 | 5,788 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-17 | Beshar Luke M (EVP & CFO) | Option Ex | 7,422 | 18.24 | 135,399 |
| 2015-02-13 | Garceau Roger (SVP & CMO) | Option Ex | 10,531 | .00 | 0 |
| 2015-02-13 | Nader Francois (President, CEO and Director) | Option Ex | 24,301 | .00 | 0 |
| 2015-02-13 | Pauwels Eric (President, NPS Pharma Int'l) | Option Ex | 8,100 | .00 | 0 |
| 2015-02-13 | Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) | Option Ex | 3,240 | .00 | 0 |
| 2015-02-13 | Beshar Luke M (EVP & CFO) | Option Ex | 10,531 | .00 | 0 |
| 2015-02-12 | Graf Susan E (VP,Corp Development & Strategy) | Option Ex | 1,445 | .00 | 0 |
| 2015-02-12 | Garceau Roger (SVP & CMO) | Option Ex | 3,832 | .00 | 0 |
| 2015-02-12 | Nader Francois (President, CEO and Director) | Option Ex | 43,804 | 10.61 | 464,935 |
| 2015-02-12 | Pauwels Eric (President, NPS Pharma Int'l) | Option Ex | 2,787 | .00 | 0 |
| 2015-02-12 | Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) | Option Ex | 1,567 | .00 | 0 |
| 2015-02-12 | Beshar Luke M (EVP & CFO) | Option Ex | 3,832 | .00 | 0 |
| 2015-02-10 | Graf Susan E (VP, Corp Development & Strateg) | Sale | 6,711 | 45.87 | 307,833 |
| 2015-02-10 | Graf Susan E (VP, Corp Development & Strateg) | Option Ex | 6,711 | 14.90 | 99,993 |
| 2015-02-05 | Garceau Roger (SVP & CMO) | Option Ex | 15,384 | 45.88 | 705,817 |
| 2015-02-05 | Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) | Sale | 32,622 | 45.90 | 1,497,251 |
| 2015-02-05 | Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) | Option Ex | 32,622 | 6.61 | 215,533 |
| 2014-12-17 | Selisker Rachel R (Director) | Sale | 3,708 | 34.59 | 128,259 |
| 2014-12-17 | Selisker Rachel R (Director) | Option Ex | 1,208 | 4.24 | 5,121 |
| 2014-12-17 | Rogus Joseph J (SVP Gbl Tech Oper Sup Chn Mgt) | Sale | 16,467 | 35.00 | 576,345 |
| 2014-12-17 | Rogus Joseph J (SVP Gbl Tech Oper Sup Chn Mgt) | Option Ex | 16,467 | 4.20 | 69,079 |
| 2014-12-17 | Beshar Luke M (EVP & CFO) | Sale | 52,258 | 35.00 | 1,829,030 |
| 2014-12-17 | Beshar Luke M (EVP & CFO) | Option Ex | 52,258 | 6.59 | 344,536 |
| 2014-12-08 | Selisker Rachel R (Director) | Sale | 23,157 | 34.50 | 798,985 |
| 2014-12-08 | Selisker Rachel R (Director) | Option Ex | 23,157 | 4.24 | 98,185 |
| 2014-11-28 | Selisker Rachel R (Director) | Sale | 11,635 | 34.50 | 401,419 |
| 2014-11-28 | Selisker Rachel R (Director) | Option Ex | 11,635 | 4.24 | 49,332 |
| 2014-11-17 | Rogus Joseph J (SVP, Gbl Technical Operations) | Sale | 26,782 | 30.00 | 803,540 |
| 2014-11-17 | Rogus Joseph J (SVP, Gbl Technical Operations) | Option Ex | 26,782 | 3.34 | 89,451 |
| 2014-11-17 | Beshar Luke M (EVP & CFO) | Sale | 47,442 | 30.01 | 1,423,639 |
| 2014-11-17 | Beshar Luke M (EVP & CFO) | Option Ex | 47,442 | 5.81 | 275,780 |
| 2014-11-11 | Selisker Rachel R (Director) | Sale | 15,188 | 29.50 | 448,091 |
| 2014-10-31 | Beshar Luke M (EVP & CFO) | Sale | 10,000 | 29.00 | 290,000 |
| 2014-10-27 | Beshar Luke M (EVP & CFO) | Sale | 30,635 | 26.75 | 819,608 |
| 2014-08-13 | Beshar Luke M (EVP & CFO) | Option Ex | 53,813 | 4.59 | 247,270 |
| 2014-08-01 | Pauwels Eric (President, NPS Pharma Int'l) | Option Ex | 1,667 | .00 | 0 |
| 2014-06-17 | Graf Susan E (VP,Corp Development & Strategy) | Option Ex | 5,788 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of NPSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nps Pharmaceuticals Inc (symbol NPSP, CIK number 890465) see the Securities and Exchange Commission (SEC) website.